Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The broader TRIUMPH clinical trial program has enrolled more than 5,800 participants across studies examining retatrutide for obesity, overweight, obstructive sleep apnea, knee osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Wegovy is FDA-approved for weight management in select individuals
Its primary use is for the treatment of major depressive disorder and seasonal affective disorder, but it is also prescribed off-label for smoking cessation, ADHD, and as an adjunct in weight management strategies
A licensed clinician reviews your profile and, if appropriate, prescribes a personalized protocol
The heterogeneity in study designs, probiotic strains used, dosages, treatment durations, and participant populations makes it difficult to draw firm conclusions
US$ 26.04
US$ 25.42
US$ 25.66
US$ 26.08
